Marc Dunoyer serves as Executive at Orchard Therapeutics plc, where they oversee executive responsibilities. Since joining the company, Marc Dunoyer has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 24, 2024 involved selling 37,179 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 24, 2024 | ORTX | $0 | Disposition | 37,179 | $N/A | Discretionary |
Marc Dunoyer currently holds 0 shares of Orchard Therapeutics plc (ORTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Dunoyer has been a net neutral trader of ORTX stock. They have purchased $0 and sold $0 worth of shares.
Marc Dunoyer's most recent insider trade was on Jan 24, 2024, when they sold 37,179 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted